Severe combined immunodeficiency (SCID): From molecular basis to clinical management

Acta Biomedica

Volumn 82, Issue 1, 2011, Pages 5-9

  Sponzilli, Ivonne ^a,b   Notarangelo, Luigi D ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Gene therapy; Hematopoietic cell transplantation; Newborn screening; Severe combined immunodeficiency

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN G; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 21 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 7; INTERLEUKIN 9; JANUS KINASE; PROTEIN KINASE ZAP 70; RAG1 PROTEIN; RAG2 PROTEIN; T LYMPHOCYTE RECEPTOR; CYTOKINE RECEPTOR;

ADENOSINE DEAMINASE DEFICIENCY; APOPTOSIS; B LYMPHOCYTE; CELL TRANSPLANTATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENGRAFTMENT; FAMILY HISTORY; GENE THERAPY; HEMATOPOIETIC CELL TRANSPLANTATION; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL PROCEDURES; IMMUNOPATHOLOGY; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTOPENIA; MEDICAL HISTORY; MUTATIONAL ANALYSIS; NATURAL KILLER T CELL; NEWBORN SCREENING; PATHOGENESIS; PHYSICAL EXAMINATION; PREVENTION AND CONTROL; PROTEIN ANALYSIS; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VDJ RECOMBINATION; ENZYME REPLACEMENT; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; NEWBORN;

B-LYMPHOCYTES; ENZYME REPLACEMENT THERAPY; GENE THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT, NEWBORN; LYMPHOCYTE COUNT; NEONATAL SCREENING; RECEPTORS, CYTOKINE; SEVERE COMBINED IMMUNODEFICIENCY; T-LYMPHOCYTES;

EID: 84856067231     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Geha RS, Notarangelo LD, Casanova JL, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 2007; 120 (4): 776-94.
2. Notarangelo LD. Primary immunodeficiencies. J Allergy Clin Immunol 2010; 125 (2 Suppl 2): S182-94.
3. Fischer A, Le Deist F, Hacein-Bey-Abina S, et al. Severe combined immunodeficiency. A model disease for molecular immunology and therapy. Immunol Rev 2005; 203: 98-109.
4. Buckley RH, Schiff RI, Schiff SE, et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 1997; 130 (3): 378-87.
5. Stephan JL, Vlekova V, Le Deist F, et al. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 1993; 123 (4): 564-72.
6. Hershfield MS. Genotype is an important determinant of phenotype in adenosine deaminase deficiency. Curr Opin Immunol 2003; 15 (5): 571-7.
7. Leonard WJ. Cytokines and immunodeficiency diseases. Nat Immunol 2002; 3 (7): 605-7.
8. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, et al. Interleukin-2 receptor gamma chain mutation results in Xlinked severe combined immunodeficiency in humans. Cell 1993; 73 (1): 147-57.
9. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998; 20 (4): 394-7.
10. Macchi P, Villa A, Giliani S, et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 1995; 377 (6544): 65-8.
11. Russell SM, Tayebi N, Nakajima H, et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 1995; 270 (5237): 797-800.
12. Schwarz K, Gauss GH, Ludwig L, et al. RAG mutations in human B cell-negative SCID. Science 1996; 274 (5284): 97-9.
13. Villa A, Santagata S, Bozzi F, et al. Partial V(D)J recombination activity leads to Omenn syndrome. Cell 1998; 93 (5): 885-96.
14. Moshous D, Callebaut I, de Chasseval R, et al. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein is mutated in human severe combined immune deficiency with increased radiosensitivity (RS-SCID). Cell 2001; 105 (2): 177-86.
15. O'Driscoll M, Cerosaletti KM, Girard PM, et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 2001; 8 (6): 1175-85.
16. Kung C, Pingel JT, Heikinheimo M, et al. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med 2000; 6 (3): 343-5.
17. Tchilian EZ, Wallace DL, Wells RS, Flower DR, Morgan G, Beverley PC. A deletion in the gene encoding the CD45 antigen in a patient with SCID. J Immunol 2001; 166 (2): 1308-13.
18. Arnaiz-Villena A, Timon M, Corell A, Perez-Aciego P, Martin-Villa JM, Regueiro JR. Brief report: primary immunodeficiency caused by mutations in the gene encoding the CD3-gamma subunit of the T-lymphocyte receptor. N Engl J Med 1992; 327 (8): 529-33.
19. Myers LA, Patel DD, Puck JM, Buckley RH. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 2002; 99 (3): 872-8.
20. Heather Finlayson. SCID lack T cells severe combined immunodeficiency (SCID)-advances in molecular diagnosis, neonatal screening and long-term management. Current Allergy & Clinical Immunology 2008; 21 (1): 20-4.
21. Malacarne F, Benicchi T, Notarangelo LD, et al. Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients. Eur J Immunol 2005; 35 (11): 3376-86.
22. William T. Shearer, Luigi D. Notarangelo, and Linda M. Griffith. Treatment of immunodeficiency: Long-term outcome and quality of life. J Allergy Clin Immunol 2008; 122 (6): 1065-8.
23. Antoine C, Muller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 2003; 361 (9357): 553-60.
24. Kane L, Gennery AR, Crooks BN, Flood TJ, Abinun M, Cant AJ. Neonatal bone marrow transplantation for severe combined immunodeficiency. Arch Dis Child Fetal Neonatal 2001; 85 (2): F110-3.
25. Ellen A. Lipstein, Sienna Vorono, Marsha F. Browning, et al. Systematic Evidence Review of Newborn Screening and Treatment of Severe Combined Immunodeficiency. Pediatrics 2010; 125 (5): e1226-35.
26. Puck JM. SCID Newborn ScreeningWorking Group. Population-based newborn screening for severe combined immunodeficiency: steps toward implementation. Immunol Res 2007; 38 (1-3): 64-7.
27. Baker MW, Grossman WJ, Laessig RH, et al. Development of a routine newborn screening protocol for severe combined immunodeficiency. J Allergy Clin Immunol 2009; 124 (3): 522-7.
28. Chase NM, Verbsky JW, Routes JM. Newborn screening for T-cell deficiency. Curr Opin Allergy Clin Immunol 2010; 10 (6): 521-5.
29. Hale JE, Bonilla FA, Pai SY, et al. Identification of an infant with severe combined immunodeficiency by newborn screening. J Allergy Clin Immunol 2010; 126 (5): 1073-4.
30. Gennery AR, Slatter MA, Grandin L et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: Entering a new century, do we do better? J Allergy Clin Immunol 2010; 126 (3): 602-10.e1-11.
31. Grunebaum E, Mazzolari E, Porta F, et al. Bone marrow transplantation for severe combined immune deficiency. JAMA 2006; 295 (5): 508-18.
32. Mazzolari E, Forino C, Guerci S, et al. Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. J Allergy Clin Immunol 2007; 120 (4): 892-9.
33. Neven B, Leroy S, Decaluwe H, et al. Long-term outcome after hematopoietic stem cell transplantation of a singlecenter cohort of 90 patients with severe combined immunodeficiency. Blood 2009; 113 (17): 4114-24.
34. Booth C, Hershfield M, Notarangelo L, et al. Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006). Clin Immunol 2007; 123 (2): 139-47.
35. Aiuti A, Cattaneo F, Galimberti S, et al. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 2009; 360 (5): 447-58.
36. Fischer A, Hacein-Bey-Abina S, Cavazanna-Calvo M. Gene therapy for primary immunodeficiencies. Immunol Allergy Clin North Am 2010; 30 (2): 237-48.